Cargando…
Proteomics Study of Peripheral Blood Mononuclear Cells in Down Syndrome Children
Down syndrome (DS) is the most common chromosomal disorder and the leading genetic cause of intellectual disability in humans, which results from the triplication of chromosome 21. To search for biomarkers for the early detection and exploration of the disease mechanisms, here, we investigated the p...
Autores principales: | Lanzillotta, Chiara, Greco, Viviana, Valentini, Diletta, Villani, Alberto, Folgiero, Valentina, Caforio, Matteo, Locatelli, Franco, Pagnotta, Sara, Barone, Eugenio, Urbani, Andrea, Di Domenico, Fabio, Perluigi, Marzia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696178/ https://www.ncbi.nlm.nih.gov/pubmed/33187268 http://dx.doi.org/10.3390/antiox9111112 |
Ejemplares similares
-
The Dysregulation of OGT/OGA Cycle Mediates Tau and APP Neuropathology in Down Syndrome
por: Zuliani, Ilaria, et al.
Publicado: (2020) -
The BACH1/Nrf2 Axis in Brain in Down Syndrome and Transition to Alzheimer Disease-Like Neuropathology and Dementia
por: Perluigi, Marzia, et al.
Publicado: (2020) -
Intranasal Administration of KYCCSRK Peptide Rescues Brain Insulin Signaling Activation and Reduces Alzheimer’s Disease-like Neuropathology in a Mouse Model for Down Syndrome
por: Tramutola, Antonella, et al.
Publicado: (2023) -
Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions
por: Dierssen, Mara, et al.
Publicado: (2020) -
Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome
por: Tramutola, Antonella, et al.
Publicado: (2018)